Novel treatment approaches and future perspectives in follicular lymphoma
Follicular lymphoma (FL) is a common B-cell malignancy characterized by relatively indolent growth and incurability with an expected lifetime course of serial intermittent treatment courses. Many patients with FL have lives shortened by the disease and despite a relatively favorable prognosis relati...
Main Authors: | Grerk Sutamtewagul, Brian K. Link |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/2040620718820510 |
Similar Items
-
Targeted Treatment of Follicular Lymphoma
by: Karthik Nath, et al.
Published: (2021-02-01) -
Controversies in the Treatment of Follicular Lymphoma
by: Kai Hübel, et al.
Published: (2020-02-01) -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01) -
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
by: Subramanian J, et al.
Published: (2017-04-01) -
Follicular lymphoma
by: Lali G. Babicheva, et al.
Published: (2020-06-01)